USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 1, 2021 | Sep 2021 | $3.31 | $3.90 | $4.31 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 1, 2021 | Sep 2021 | $832.52M | $751.81M | $600.89M |
Jazz Pharmaceuticals's next earnings date is Monday, Nov 1, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 18 | $3.41 | $2.71 | $3.94 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 15 | $14.52 | $13.76 | $15.29 |
| Dec 2022 | 18 | $17.44 | $14.52 | $20.16 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 2 / 0 | $3.43 | $3.43 | $3.74 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 2 / 0 | $14.50 | $14.49 | $14.55 |
| Dec 2022 | 3 / 0 | $17.66 | $17.59 | $17.90 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 16 | $889.99M | $864.00M | $922.00M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 17 | $3.09B | $3.04B | $3.16B |
| Dec 2022 | 18 | $3.72B | $3.50B | $4.01B |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 1, 2021 | Sep 2021 | $3.31 | - | - |
| Aug 3, 2021 | Jun 2021 | $3.45 | $3.90 | 13.15% |
| May 4, 2021 | Mar 2021 | $3.73 | $3.92 | 4.98% |
| Feb 23, 2021 | Dec 2020 | $4.20 | $4.00 | -4.82% |
| Nov 2, 2020 | Sep 2020 | $4.08 | $4.31 | 5.74% |
| Aug 4, 2020 | Jun 2020 | $3.11 | $3.71 | 19.20% |
| May 5, 2020 | Mar 2020 | $0.67 | $0.45 | -33.04% |
| Feb 25, 2020 | Dec 2019 | $4.12 | $4.42 | 7.27% |
| Nov 5, 2019 | Sep 2019 | $3.59 | $4.10 | 14.05% |
| Aug 6, 2019 | Jun 2019 | $3.57 | $4.05 | 13.39% |
| May 7, 2019 | Mar 2019 | $3.16 | $3.67 | 16.17% |
| Feb 26, 2019 | Dec 2018 | $3.03 | $3.64 | 20.22% |
| Nov 6, 2018 | Sep 2018 | $3.32 | $3.58 | 7.84% |
| Aug 7, 2018 | Jun 2018 | $3.21 | $3.49 | 8.75% |
| May 8, 2018 | Mar 2018 | $2.78 | $2.98 | 7.19% |
| Feb 27, 2018 | Dec 2017 | $2.96 | $2.95 | -0.39% |
| Nov 7, 2017 | Sep 2017 | $2.89 | $3.22 | 11.50% |
| Aug 8, 2017 | Jun 2017 | $2.75 | $2.56 | -6.93% |
| May 9, 2017 | Mar 2017 | $2.34 | $2.31 | -1.26% |
| Feb 28, 2017 | Dec 2016 | $2.65 | $2.71 | 2.12% |
| Nov 8, 2016 | Sep 2016 | $2.61 | $2.57 | -1.53% |
| Aug 9, 2016 | Jun 2016 | $2.81 | $2.63 | -6.32% |
| May 10, 2016 | Mar 2016 | $2.32 | $2.26 | -2.70% |
| Feb 23, 2016 | Dec 2015 | $2.60 | $2.60 | 0.14% |
| Nov 9, 2015 | Sep 2015 | $2.56 | $2.52 | -1.56% |
| Aug 5, 2015 | Jun 2015 | $2.41 | $2.41 | - |
| May 7, 2015 | Mar 2015 | $2.15 | $1.99 | -7.44% |
| Feb 24, 2015 | Dec 2014 | $2.30 | $2.44 | 6.09% |
| Nov 4, 2014 | Sep 2014 | $2.22 | $2.33 | 4.96% |
| Aug 5, 2014 | Jun 2014 | $1.92 | $2.05 | 6.77% |
| May 8, 2014 | Mar 2014 | $1.79 | $1.61 | -10.06% |
| Feb 25, 2014 | Dec 2013 | $1.78 | $1.72 | -3.37% |
| Nov 5, 2013 | Sep 2013 | $1.67 | $1.78 | 6.59% |
| Aug 6, 2013 | Jun 2013 | $1.52 | $1.43 | -5.92% |
| May 7, 2013 | Mar 2013 | $1.35 | $1.37 | 1.48% |
| Feb 26, 2013 | Dec 2012 | $1.42 | $1.53 | 7.75% |
| Nov 8, 2012 | Sep 2012 | $1.32 | $1.29 | -2.27% |
| Aug 7, 2012 | Jun 2012 | $1.05 | $1.09 | 3.81% |
| May 8, 2012 | Mar 2012 | $0.84 | $0.91 | 8.33% |
| Feb 27, 2012 | Dec 2011 | $1.09 | $1.17 | 7.34% |
| Nov 1, 2011 | Sep 2011 | $0.94 | $0.94 | - |
| Jul 28, 2011 | Jun 2011 | $0.79 | $0.82 | 3.80% |
| May 3, 2011 | Mar 2011 | $0.57 | $0.59 | 3.51% |
| Mar 7, 2011 | Dec 2010 | $0.60 | $0.63 | 5.00% |
| Nov 4, 2010 | Sep 2010 | $0.34 | $0.41 | 20.59% |
| Aug 10, 2010 | Jun 2010 | $0.14 | $0.28 | 100.00% |
| May 5, 2010 | Mar 2010 | $0.18 | $0.18 | - |
| Mar 3, 2010 | Dec 2009 | $0.07 | $0.17 | 142.86% |
| Nov 5, 2009 | Sep 2009 | $-0.14 | $-0.05 | 64.29% |
| Aug 11, 2009 | Jun 2009 | $-0.32 | $0.07 | 121.88% |
| May 7, 2009 | Mar 2009 | - | $-0.45 | - |
| Mar 26, 2009 | Dec 2008 | $-1.07 | $-2.04 | -90.65% |
| Nov 13, 2008 | Sep 2008 | $-1.29 | $-1.07 | 17.05% |
| Aug 7, 2008 | Jun 2008 | $-1.78 | $-2.17 | -21.91% |
| May 13, 2008 | Mar 2008 | $-1.57 | $-1.97 | -25.48% |
| Feb 13, 2008 | Dec 2007 | $-1.82 | $-1.69 | 7.14% |
| Nov 6, 2007 | Sep 2007 | $-1.40 | $-0.82 | 41.43% |
| Aug 9, 2007 | Jun 2007 | $-1.69 | $-1.38 | 18.34% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 23, 2021 | Dec 2020 | $12.60 | $12.47 | -1.03% |
| Feb 25, 2020 | Dec 2019 | $15.91 | $16.24 | 2.07% |
| Feb 26, 2019 | Dec 2018 | $13.07 | $13.69 | 4.74% |
| Feb 27, 2018 | Dec 2017 | $11.09 | $11.04 | -0.45% |
| Feb 28, 2017 | Dec 2016 | - | $10.17 | - |
| Feb 23, 2016 | Dec 2015 | - | $9.52 | - |
| Feb 24, 2015 | Dec 2014 | - | $8.43 | - |
| Feb 25, 2014 | Dec 2013 | - | $6.30 | - |
| Feb 26, 2013 | Dec 2012 | - | $4.82 | - |
| Feb 27, 2012 | Dec 2011 | - | $3.52 | - |
| Mar 7, 2011 | Dec 2010 | - | $1.50 | - |
| Mar 3, 2010 | Dec 2009 | - | $-0.26 | - |
| Mar 26, 2009 | Dec 2008 | - | $-7.25 | - |
| Feb 13, 2008 | Dec 2007 | - | $-3.89 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 1, 2021 | Sep 2021 | $832.52M | - | - |
| Aug 3, 2021 | Jun 2021 | $751.81M | $751.81M | 1.00% |
| May 4, 2021 | Mar 2021 | $607.58M | $607.58M | 1.00% |
| Feb 23, 2021 | Dec 2020 | $639.55M | $665.52M | 1.04% |
| Nov 2, 2020 | Sep 2020 | $577.58M | $600.89M | 1.04% |
| Aug 4, 2020 | Jun 2020 | $504.65M | $562.44M | 1.11% |
| May 5, 2020 | Mar 2020 | $544.55M | $534.73M | 0.98% |
| Feb 25, 2020 | Dec 2019 | $562.02M | $581.74M | 1.04% |
| Nov 5, 2019 | Sep 2019 | $525.16M | $537.70M | 1.02% |
| Aug 6, 2019 | Jun 2019 | $508.62M | $534.13M | 1.05% |
| May 7, 2019 | Mar 2019 | $465.95M | $508.19M | 1.09% |
| Feb 26, 2019 | Dec 2018 | $459.72M | $476.46M | 1.04% |
| Nov 6, 2018 | Sep 2018 | $482.48M | $469.37M | 0.97% |
| Aug 7, 2018 | Jun 2018 | $469.62M | $500.50M | 1.07% |
| May 8, 2018 | Mar 2018 | $435.46M | $444.60M | 1.02% |
| Feb 27, 2018 | Dec 2017 | $441.31M | $436.40M | 0.99% |
| Nov 7, 2017 | Sep 2017 | $421.00M | $411.90M | 0.98% |
| Aug 8, 2017 | Jun 2017 | $410.51M | $394.40M | 0.96% |
| May 9, 2017 | Mar 2017 | - | $376.10M | - |
| Feb 28, 2017 | Dec 2016 | - | $396.60M | - |
| Nov 8, 2016 | Sep 2016 | - | $374.20M | - |
| Aug 9, 2016 | Jun 2016 | - | $381.20M | - |
| May 10, 2016 | Mar 2016 | - | $336.00M | - |
| Feb 23, 2016 | Dec 2015 | - | $340.90M | - |
| Nov 9, 2015 | Sep 2015 | - | $340.90M | - |
| Aug 5, 2015 | Jun 2015 | - | $333.70M | - |
| May 7, 2015 | Mar 2015 | - | $309.30M | - |
| Feb 24, 2015 | Dec 2014 | - | $328.10M | - |
| Nov 4, 2014 | Sep 2014 | - | $306.60M | - |
| Aug 5, 2014 | Jun 2014 | - | $291.20M | - |
| May 8, 2014 | Mar 2014 | - | $246.90M | - |
| Feb 25, 2014 | Dec 2013 | - | $235.80M | - |
| Nov 5, 2013 | Sep 2013 | - | $232.20M | - |
| Aug 6, 2013 | Jun 2013 | - | $208.30M | - |
| May 7, 2013 | Mar 2013 | - | $196.20M | - |
| Feb 26, 2013 | Dec 2012 | - | $183.70M | - |
| Nov 8, 2012 | Sep 2012 | - | $175.50M | - |
| Aug 7, 2012 | Jun 2012 | - | $124.20M | - |
| May 8, 2012 | Mar 2012 | - | $102.50M | - |
| Feb 27, 2012 | Dec 2011 | - | $83.50M | - |
| Nov 1, 2011 | Sep 2011 | - | $73.30M | - |
| Jul 28, 2011 | Jun 2011 | - | $64.60M | - |
| May 3, 2011 | Mar 2011 | - | $50.90M | - |
| Mar 7, 2011 | Dec 2010 | - | $53.40M | - |
| Nov 4, 2010 | Sep 2010 | - | $44.80M | - |
| Aug 10, 2010 | Jun 2010 | - | $40.50M | - |
| May 5, 2010 | Mar 2010 | - | $35.20M | - |
| Mar 3, 2010 | Dec 2009 | - | $38.30M | - |
| Nov 5, 2009 | Sep 2009 | - | $30.80M | - |
| Aug 11, 2009 | Jun 2009 | - | $37.30M | - |
| May 7, 2009 | Mar 2009 | - | $22.10M | - |
| Mar 26, 2009 | Dec 2008 | - | $19.60M | - |
| Nov 13, 2008 | Sep 2008 | - | $17.80M | - |
| Aug 7, 2008 | Jun 2008 | - | $15.60M | - |
| May 13, 2008 | Mar 2008 | - | $14.60M | - |
| Feb 13, 2008 | Dec 2007 | - | $15.50M | - |
| Nov 6, 2007 | Sep 2007 | - | $21.50M | - |
| Aug 9, 2007 | Jun 2007 | - | $14.26M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 23, 2021 | Dec 2020 | $2.34B | $2.36B | 1.08% |
| Feb 25, 2020 | Dec 2019 | $2.14B | $2.16B | 0.95% |
| Feb 26, 2019 | Dec 2018 | $1.87B | $1.89B | 0.85% |
| Feb 27, 2018 | Dec 2017 | $1.62B | $1.62B | -0.28% |
| Feb 28, 2017 | Dec 2016 | - | $1.49B | - |
| Feb 23, 2016 | Dec 2015 | - | $1.32B | - |
| Feb 24, 2015 | Dec 2014 | - | $1.17B | - |
| Feb 25, 2014 | Dec 2013 | - | $872.40M | - |
| Feb 26, 2013 | Dec 2012 | - | $586.00M | - |
| Feb 27, 2012 | Dec 2011 | - | $272.30M | - |
| Mar 7, 2011 | Dec 2010 | - | $173.70M | - |
| Mar 3, 2010 | Dec 2009 | - | $128.40M | - |
| Mar 26, 2009 | Dec 2008 | - | $67.50M | - |
| Feb 13, 2008 | Dec 2007 | - | $65.30M | - |
JAZZ's next earnings date is Monday, Nov 1, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 18 analysts, the average EPS estimation for Jazz Pharmaceuticals's next quarterly earnings is $3.31, with a low EPS estimation of $2.99, and a high estimation of $3.69.
Over the last 1 month, EPS estimates have seen 5 upward revisions and 0 downward. The EPS 1 month trend is $3.26, the last 2 month trend is $3.26, and the 3 month trend is $3.36.
Based on 14 analysts, the average revenue estimation is $832.52M, with a low revenue estimation of $789.00M, and a high estimation of $860.50M.
Jazz Pharmaceuticals's previous earnings date was Aug 3, 2021 for its fiscal quarter ended Jun 30, 2021.
JAZZ's earnings per share (EPS) was $3.90, beating the consensus analysts forecast of $3.45 by 13.15%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by -0.51%, and higher than the same period a year before (Jun 2020) by 5.12%.
Revenues were $751.81M, better than the forecast of $751.81M by 0.00%, up by 23.74% from the previous quarter , and up by 33.67% from the same period last year.
The company reported a net income of $-363.32M.Free cash flow for the quarter was $34.52M , compared to $282.83M last quarter and $76.83M a year before.
JAZZ ended the quarter with $6.92B in total debt, an increase of 207.11% compared to the previous quarter, and an increase of 228.82% compared to the same quarter a year before.
Jazz Pharmaceuticals's previous annual earnings date was Feb 23, 2021 for its fiscal year ended Dec 31, 2020.
JAZZ's earnings per share (EPS) was $12.47, missing the consensus analysts forecast of $12.60 by -1.03% , and lower than the previous year's EPS (Dec 2019) by -23.21%.
Revenues were $2.36B, better than the forecast of $2.34B by 1.08%, and up by 9.34% from previous year's revenue.
The company reported a net income of $238.62M, -54.41% lower than the previous year.
Jazz Pharmaceuticals reported a free cash flow of $520.39M for its fiscal year, compared to $594.07M a year ago.
The company ended the fiscal year with $2.11B in total debt, an increase of 30.20% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
